J&J Employs L’Oreal-Did-It-So-Why-Can’t-We Defense In NAD Case
This article was originally published in The Rose Sheet
Executive Summary
The National Advertising Division recommends that Johnson & Johnson discontinue and modify claims for its Neutrogena Rapid Wrinkle Repair Moisturizer (Night), rejecting a consumer perception study that J&J claims is modeled after a L’Oreal study the watchdog group praised in a November 2010 case.
You may also be interested in...
J&J Skin Care Continues Apace With ‘Rapid’ Products, ‘1 Week’ Claims
Regulatory and legal challenges have not held back J&J/Neutrogena’s Rapid Wrinkle Repair business, which has been joined by a Rapid Tone Repair line and Rapid Clear acne treatments. Meanwhile, new Aveeno Absolutely Ageless products similarly provide results in just one week, the company says.
Maybelline Substantiates Anti-Aging Claims In NAD Case
Maybelline New York demonstrated that claims its Instant Age Rewind Eraser Treatment Makeup foundation could “erase” signs of aging merely play on the product name and are not taken literally by consumers, according to the National Advertising Division.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.